V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10330346 | 10039749 | 1.68 | 65 | Curative (C) | 2019-03-13 | 2019-04-25 | Cyclophosphamide + Docetaxel | 02 | N | BUSULFAN | 101534857 |
| 10330398 | 10039751 | 1.65 | 143.5 | null | 2019-04-17 | 2019-05-17 | Palbociclib | 02 | Y | PALBOCICLIB | 100291968 |
| 10330421 | 10039752 | 1.57 | null | null | null | 2018-12-16 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100171223 |
| 10330567 | 10039753 | 1.66 | 62 | Disease modification (D) | 2021-07-11 | 2021-09-01 | Folfirinox | 02 | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101347162 |
| 10330577 | 10039754 | 1.75 | null | null | 2016-12-16 | 2016-12-16 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | null | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100782587 |
| 10330707 | 10039757 | 1.64 | 72.5 | 03 | 2020-02-19 | 2020-02-26 | TEMOZOLOMIDE | 02 | null | TEMOZOLOMIDE | 100439817 |
| 10330803 | 10039758 | 1.71 | 67 | null | 2018-03-04 | 2018-03-10 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | N | null | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100758800 |
| 10330852 | 10039761 | 1.88 | 54.6 | Adjuvant (A) | 2018-01-29 | 2018-02-05 | CVP R | N | N | CISPLATIN + VINORELBINE | 100971668 |
| 10330979 | 10039763 | 1.46 | 90.45 | null | 2019-11-19 | 2019-11-21 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | null | TRIAL | 100452643 |
| 10331112 | 10039764 | 1.73 | 67.8 | Disease modification (D) | 2018-05-27 | 2018-06-14 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101041789 |
| 10331273 | 10039767 | 1.66 | 84.7 | Palliative (P) | 2018-07-15 | 2018-07-22 | Trial Unspecified | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101694661 |
| 10331321 | 10039768 | 1.69 | 72.7 | null | 2017-04-16 | 2017-04-16 | Sunitinib | 02 | null | POMALIDOMIDE | 100687347 |
| 10331403 | 10039770 | 1.82 | 79.6 | null | 2020-08-30 | 2020-09-07 | Cytarabine Low Dose | 02 | null | PAZOPANIB | 100152013 |
| 10331437 | 10039771 | 1.61 | 64 | 03 | 2018-03-08 | 2018-03-17 | R Chlorambucil | 02 | N | CHLORAMBUCIL + RITUXIMAB | 100827156 |
| 10331489 | 10039772 | 1.66 | 58 | Not known (9) | null | 2016-05-02 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | Y | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100947057 |
| 10331769 | 10039776 | 1.81 | 96.5 | Palliative (P) | 2019-04-04 | 2019-04-07 | FLUOROURACIL | 02 | N | FLUOROURACIL | 100613001 |
| 10331831 | 10039778 | 1.65 | null | null | 2018-01-22 | 2018-01-22 | Acalabrutinib | 02 | null | ACALABRUTINIB | 100574075 |
| 10331844 | 10039779 | 1.6 | 78.7 | Curative (C) | 2021-07-22 | 2021-07-22 | Folfirinox | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100976145 |
| 10331888 | 10039780 | null | 0 | Palliative (P) | 2021-04-19 | 2021-04-19 | R GCVP | N | N | CYTARABINE | 100167021 |
| 10331998 | 10039782 | 1.54 | 100.3 | Palliative (P) | 2019-08-05 | 2019-08-05 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 100211258 |
| 10332007 | 10039783 | 1.52 | 62 | null | 2019-03-05 | 2019-03-27 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | N | SUNITINIB | 100560808 |
| 10332008 | 10039784 | 1.75 | null | Palliative (P) | 2020-03-27 | 2020-03-28 | CISPLATIN + VINORELBINE | 99 | N | DABRAFENIB + TRAMETINIB | 101769505 |
| 10332048 | 10039785 | 1.51 | 0 | Adjuvant (A) | 2019-04-17 | 2019-04-26 | CHOP R | N | N | CHOP R | 100519369 |
| 10332084 | 10039786 | 1.57 | 81 | Neo-adjuvant (N) | 2019-12-10 | 2019-12-10 | Cytarabine Low Dose | 02 | N | VENETOCLAX | 101150308 |
| 10332121 | 10039787 | 1.78 | 75.4 | Curative (C) | 2019-03-17 | 2019-03-27 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | null | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101122890 |
| 10332146 | 10039788 | null | 0 | null | 2019-08-12 | 2019-08-31 | CYCLOPHOSPHAMIDE + RITUXIMAB + Dexamethasone | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101600024 |
| 10332178 | 10039789 | 1.81 | 103 | 03 | 2020-12-29 | 2021-01-11 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 101843990 |
| 10332197 | 10039790 | 1.77 | 60 | null | 2018-03-18 | 2018-03-18 | R Chlorambucil | 02 | null | CHLORAMBUCIL + RITUXIMAB | 100121129 |
| 10332234 | 10039791 | 0 | 0 | Palliative (P) | 2018-09-15 | 2018-09-15 | Sunitinib | 02 | N | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 101818860 |
| 10332249 | 10039793 | 0 | 0 | Curative (C) | 2018-06-24 | 2018-07-01 | BUSULFAN | 02 | N | CVP R | 100366434 |
| 10332272 | 10039794 | 1.54 | 63.1 | null | 2017-08-15 | 2017-08-19 | Cyclophosphamide + Docetaxel | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100998486 |
| 10332362 | 10039796 | null | null | Neo-adjuvant (N) | 2020-12-17 | 2020-12-28 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 100373893 |
| 10332384 | 10039797 | 1.73 | 82.8 | null | 2018-11-01 | 2018-11-04 | POMALIDOMIDE | 02 | null | SUNITINIB | 100402818 |
| 10332419 | 10039798 | 1.63 | null | Curative (C) | 2019-09-05 | 2019-10-14 | Cytarabine Low Dose | null | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101529331 |
| 10332422 | 10039799 | 1.59 | 87.5 | Curative (C) | 2017-10-08 | 2017-11-04 | Cyclophosphamide + Dex + Rituximab | 02 | N | CAPECITABINE + GEMCITABINE | 101626166 |
| 10332424 | 10039800 | null | 0 | Palliative (P) | 2020-02-06 | 2020-02-25 | DABRAFENIB + TRAMETINIB | 02 | N | TRIAL | 100110280 |
| 10332527 | 10039804 | 1.58 | 88.8 | Curative (C) | null | 2017-07-31 | BORTEZOMIB + THALIDOMIDE | 02 | null | BORTEZOMIB + THALIDOMIDE | 100934107 |
| 10332546 | 10039806 | 1.72 | 71.1 | Curative (C) | 2018-02-25 | 2018-02-25 | Sunitinib | 02 | null | SUNITINIB | 100921201 |
| 10332551 | 10039807 | 1.76 | 69 | Palliative (P) | 2017-06-01 | 2017-06-08 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CAPECITABINE + CISPLATIN | 100988081 |
| 10332640 | 10039808 | 1.56 | 109 | Palliative (P) | 2020-02-01 | 2020-02-01 | Pazopanib | 02 | N | VENETOCLAX | 100038484 |
| 10332674 | 10039809 | 1.77 | 99.1 | null | 2020-01-22 | 2020-02-10 | Irinotecan + Modified De Gramont | 02 | null | FLUOROURACIL + IRINOTECAN | 100583567 |
| 10332677 | 10039810 | 1.51 | 90.45 | Curative (C) | 2019-06-26 | 2019-07-18 | Trial Unspecified | 02 | N | DABRAFENIB + TRAMETINIB | 100425584 |
| 10332732 | 10039811 | 1.52 | 81.8 | Palliative (P) | 2020-07-04 | 2020-07-08 | FEC 100 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101500366 |
| 10332858 | 10039813 | 0 | 0 | Palliative (P) | 2020-02-16 | 2020-02-16 | Folfirinox/ Folfoxiri | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101331475 |
| 10332867 | 10039814 | 1.75 | 68 | Disease modification (D) | 2022-02-20 | 2022-02-20 | DARATUMUMAB | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 101558529 |
| 10332947 | 10039815 | 1.68 | 114.2 | Disease modification (D) | 2016-04-21 | 2016-05-19 | null | 02 | N | DARATUMUMAB | 100849928 |
| 10332961 | 10039816 | 0 | 0 | Palliative (P) | 2019-12-30 | 2020-01-06 | Venetoclax | 02 | N | CAPECITABINE + GEMCITABINE | 100590019 |
| 10332984 | 10039817 | 1.65 | 82.4 | Disease modification (D) | 2016-05-12 | 2016-05-19 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | N | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 101075859 |
| 10333023 | 10039818 | 1.72 | 96 | Adjuvant (A) | 2019-04-26 | 2019-05-26 | Pazopanib | null | N | PAZOPANIB | 100192278 |
| 10333027 | 10039819 | null | null | Palliative (P) | null | 2017-05-17 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | N | CVP R | 101560667 |